Read more:
DOI:
10.14202/vetworld.2022.182-187
DOI is the universal ID for this study.
This link will take you to the full study.
Materials and methods: A total of 30 male Wistar rats were randomly divided into five groups: Normal (N), DM rats, DM+metformin (DM+Met, 45 mg/kg body weight [BW]), DM+Met+HW, and DM+HW. DM rats were induced by feeding them a high-fat diet for 30 days and then injecting with repeated low doses of STZ (35 mg/kg BW) intraperitoneally. Fresh HW was administered orally and ad libitum for 14 days. Insulin, IRs, and SOD were observed in each group.
Results: HW therapy increased the level and expression of insulin and IRs. In addition, treatment with HW also elevated the SOD levels in the serum and liver. The study results indicated no significant differences between the administration of HW and metformin.
Conclusion: HW has antioxidant activity in STZ-induced DM rats, increasing insulin, IRs, and SOD.
Publish Year | 2022 |
---|---|
Country | Indonesia |
Rank | Positive |
Journal | Veterinary World |
Primary Topic | Whole Body |
Secondary Topic | Diabetes |
Model | Rat |
Tertiary Topic | Glucose Metabolism |
Vehicle | Water (Electrolysis) |
pH | Neutral |
Application | Ingestion |
Comparison | |
Complement |